- Home
- REXR vs ARWR Comparison
REXR vs ARWR Comparison
Compare REXR & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | ARWR |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.6B |
| IPO Year | 2013 | 1993 |
Fundamental Metrics
Financial Performance| Metric | REXR | ARWR |
|---|---|---|
| Price | $41.17 | $68.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $43.10 | ★ $60.70 |
| AVG Volume (30 Days) | 2.2M | ★ 3.3M |
| Earning Date | 02-04-2026 | 11-25-2025 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 15.85 | N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $997,931,000.00 | $829,448,000.00 |
| Revenue This Year | $9.35 | N/A |
| Revenue Next Year | $3.81 | N/A |
| P/E Ratio | $28.97 | ★ N/A |
| Revenue Growth | 10.40 | ★ 23258.15 |
| 52 Week Low | $29.68 | $9.57 |
| 52 Week High | $44.38 | $72.36 |
Technical Indicators
Market Signals| Indicator | REXR | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 50.53 | 73.21 |
| Support Level | $39.53 | $68.01 |
| Resistance Level | $41.96 | $72.36 |
| Average True Range (ATR) | 0.76 | 4.99 |
| MACD | 0.05 | 1.04 |
| Stochastic Oscillator | 65.35 | 87.26 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.